Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $44.8 million.

  • Veracyte's Cash from Operations rose 4937.42% to $44.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.2 million, marking a year-over-year increase of 6370.46%. This contributed to the annual value of $75.1 million for FY2024, which is 6981.59% up from last year.
  • Veracyte's Cash from Operations amounted to $44.8 million in Q3 2025, which was up 4937.42% from $33.6 million recorded in Q2 2025.
  • Over the past 5 years, Veracyte's Cash from Operations peaked at $44.8 million during Q3 2025, and registered a low of -$40.6 million during Q1 2021.
  • Moreover, its 5-year median value for Cash from Operations was $8.4 million (2021), whereas its average is $9.4 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first crashed by 66515.75% in 2021, then skyrocketed by 469256.2% in 2023.
  • Quarter analysis of 5 years shows Veracyte's Cash from Operations stood at $8.4 million in 2021, then grew by 15.37% to $9.7 million in 2022, then surged by 59.61% to $15.6 million in 2023, then surged by 57.69% to $24.5 million in 2024, then soared by 82.5% to $44.8 million in 2025.
  • Its Cash from Operations was $44.8 million in Q3 2025, compared to $33.6 million in Q2 2025 and $5.4 million in Q1 2025.